Cargando…

Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage

BACKGROUND: Alzheimer’s disease (AD) etiopathogenesis remains partially unexplained. The main conceptual framework used to study AD is the Amyloid Cascade Hypothesis, although the failure of recent clinical experimentation seems to reduce its potential in AD research. OBJECTIVE: A possible explanati...

Descripción completa

Detalles Bibliográficos
Autores principales: Caligiore, Daniele, Silvetti, Massimo, D’Amelio, Marcello, Puglisi-Allegra, Stefano, Baldassarre, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592658/
https://www.ncbi.nlm.nih.gov/pubmed/32741822
http://dx.doi.org/10.3233/JAD-200276
_version_ 1783601230073823232
author Caligiore, Daniele
Silvetti, Massimo
D’Amelio, Marcello
Puglisi-Allegra, Stefano
Baldassarre, Gianluca
author_facet Caligiore, Daniele
Silvetti, Massimo
D’Amelio, Marcello
Puglisi-Allegra, Stefano
Baldassarre, Gianluca
author_sort Caligiore, Daniele
collection PubMed
description BACKGROUND: Alzheimer’s disease (AD) etiopathogenesis remains partially unexplained. The main conceptual framework used to study AD is the Amyloid Cascade Hypothesis, although the failure of recent clinical experimentation seems to reduce its potential in AD research. OBJECTIVE: A possible explanation for the failure of clinical trials is that they are set too late in AD progression. Recent studies suggest that the ventral tegmental area (VTA) degeneration could be one of the first events occurring in AD progression (pre-plaque stage). METHODS: Here we investigate this hypothesis through a computational model and computer simulations validated with behavioral and neural data from patients. RESULTS: We show that VTA degeneration might lead to system-level adjustments of catecholamine release, triggering a sequence of events leading to relevant clinical and pathological signs of AD. These changes consist first in a midfrontal-driven compensatory hyperactivation of both VTA and locus coeruleus (norepinephrine) followed, with the progression of the VTA impairment, by a downregulation of catecholamine release. These processes could then trigger the neural degeneration at the cortical and hippocampal levels, due to the chronic loss of the neuroprotective role of norepinephrine. CONCLUSION: Our novel hypothesis might contribute to the formulation of a wider system-level view of AD which might help to devise early diagnostic and therapeutic interventions.
format Online
Article
Text
id pubmed-7592658
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-75926582020-10-30 Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage Caligiore, Daniele Silvetti, Massimo D’Amelio, Marcello Puglisi-Allegra, Stefano Baldassarre, Gianluca J Alzheimers Dis Research Article BACKGROUND: Alzheimer’s disease (AD) etiopathogenesis remains partially unexplained. The main conceptual framework used to study AD is the Amyloid Cascade Hypothesis, although the failure of recent clinical experimentation seems to reduce its potential in AD research. OBJECTIVE: A possible explanation for the failure of clinical trials is that they are set too late in AD progression. Recent studies suggest that the ventral tegmental area (VTA) degeneration could be one of the first events occurring in AD progression (pre-plaque stage). METHODS: Here we investigate this hypothesis through a computational model and computer simulations validated with behavioral and neural data from patients. RESULTS: We show that VTA degeneration might lead to system-level adjustments of catecholamine release, triggering a sequence of events leading to relevant clinical and pathological signs of AD. These changes consist first in a midfrontal-driven compensatory hyperactivation of both VTA and locus coeruleus (norepinephrine) followed, with the progression of the VTA impairment, by a downregulation of catecholamine release. These processes could then trigger the neural degeneration at the cortical and hippocampal levels, due to the chronic loss of the neuroprotective role of norepinephrine. CONCLUSION: Our novel hypothesis might contribute to the formulation of a wider system-level view of AD which might help to devise early diagnostic and therapeutic interventions. IOS Press 2020-09-01 /pmc/articles/PMC7592658/ /pubmed/32741822 http://dx.doi.org/10.3233/JAD-200276 Text en © 2020 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Caligiore, Daniele
Silvetti, Massimo
D’Amelio, Marcello
Puglisi-Allegra, Stefano
Baldassarre, Gianluca
Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
title Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
title_full Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
title_fullStr Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
title_full_unstemmed Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
title_short Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
title_sort computational modeling of catecholamines dysfunction in alzheimer’s disease at pre-plaque stage
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592658/
https://www.ncbi.nlm.nih.gov/pubmed/32741822
http://dx.doi.org/10.3233/JAD-200276
work_keys_str_mv AT caligioredaniele computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage
AT silvettimassimo computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage
AT dameliomarcello computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage
AT puglisiallegrastefano computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage
AT baldassarregianluca computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage